ASB-20893-62809
3 vaccinations
5 coded responses
30 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 037 / NH
- Registered
- 2022-09-26
- Relationship
- Child or adolescent in my care
- Guardian
- LRA-24825-37180
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-26
Registered in v-safe
-
2022-09-26
Dose 1 — Pfizer-BioNTechCo-administered: Flu:Hib:Rotavirus:Tetanus
-
2022-09-26
Health check-in — day 0, dose 1, under 3Feeling: Poor · Site: Pain · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend schoolUnder 3 check-in
-
2022-09-27
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Site: Pain · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend schoolUnder 3 check-in
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-05
-
2022-10-10
Survey response — day 14, dose 1, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cough and runny nose, chest congratulationsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2022-10-24
-
2022-10-25
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-08
-
2022-11-15
Survey response — day 21, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Yet another coldMedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Survey response — day 28, dose 2, under 3MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach fluMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Survey response — day 35, dose 2, under 3MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-06
-
2023-01-17
Dose 3 — Pfizer-BioNTech
- 2023-01-24
- 2023-01-24
- 2023-01-31
- 2023-02-07
- 2023-02-14
- 2023-02-21
-
2023-02-28
Survey response — day 42, dose 3, under 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-26 | Pfizer-BioNTech | Flu:Hib:Rotavirus:Tetanus |
| 2 | 2022-10-25 | Pfizer-BioNTech | Flu |
| 3 | 2023-01-17 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Cough and runny nose, chest congratulations
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Yet another cold
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Stomach flu
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Fever and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release